BackMyriad Genetics Overview

Myriad Genetics Other Current Assets

Track Myriad Genetics's other current assets ($34M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$33.70M
↓ 23.76% YoYΔ $-10.50M vs prior year quarter

Peer average / median

Loading

Myriad Genetics Other Current Assets History

Loading

Myriad Genetics vs. peers: Other Current Assets Comparison

Loading

Myriad Genetics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Myriad Genetics (MYGN) FAQ

As of the most recent data (June 2026), MYGN shows a other current assets of $34M. That compares with $44M in the prior-year period — down 23.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MYGN's other current assets is now $34M (was $44M) — a 23.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Myriad Genetics is outperforming or lagging.

Tracking MYGN's other current assets over time shows whether Myriad Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $34M That compares with $44M in the prior-year period — down 23.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Myriad Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $34M) with ownership activity and broader fundamentals.

Myriad Genetics's other current assets is $34M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.